Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors
Because of insufficient migration and antitumor function of transferred T cells, especially inside the immunosuppressive tumor microenvironment (TME), the efficacy of adoptive cell transfer (ACT) is much curtailed in treating solid tumors. To overcome these challenges, we sought to reenergize ACT (R...
Main Authors: | Xin, Gang, Schauder, David M., Jing, Weiqing, Jiang, Aimin, Johnson, Bryon, Cui, Weiguo, Joshi, Nik |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2017
|
Online Access: | http://hdl.handle.net/1721.1/111219 https://orcid.org/0000-0002-7045-7837 |
Similar Items
-
The power of combining adoptive cell therapy (ACT) and pathogen-boosted vaccination to treat solid tumors
by: Ryan Zander, et al.
Published: (2017-10-01) -
Adoptive Cellular Transfer Immunotherapies for Cancer
by: Panagiotis Parsonidis, et al.
Published: (2022-01-01) -
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
by: Qiaofei Liu, et al.
Published: (2023-02-01) -
Editorial: Novel immunotherapies to treat gastrointestinal solid tumor cancers
by: Sripathi M. Sureban, et al.
Published: (2022-10-01) -
Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
by: Oelke, M, et al.
Published: (2000)